This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1996
Title: Innovations of Hans-Peter Muhn-Seipoldy
Introduction
Hans-Peter Muhn-Seipoldy is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, his work reflects a commitment to advancing medical science.
Latest Patents
His latest patents include "11.beta.-substituted 14,17-ethanoestratrienes" and "Functionalized vinyl azoles and methods of use." These patents focus on pharmaceutical preparations that comprise functionalized vinyl azoles of specific formulas. The innovations include novel compounds, methods of use, and methods of preparation, showcasing his expertise in the pharmaceutical domain.
Career Highlights
Hans-Peter Muhn-Seipoldy is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to contribute to significant advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Rolf Bohlmann and Yukishige Nishino. These partnerships have likely enhanced the scope and impact of his research and innovations.
Conclusion
Hans-Peter Muhn-Seipoldy exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile